Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: The possible role of metabolic control and oxidative stress

Metabolism: Clinical and Experimental

Volumn 45, Issue 4, 1996, Pages 498-501

  Ceriello, Antonio ^a   Falleti, Edmondo ^a   Bortolotti, Nadia ^a   Motz, Enrico ^a   Cavarape, Alessandro ^a   Russo, Assunta ^a   Gonano, Fabio ^a   Bartoli, Ettore ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INTERCELLULAR ADHESION MOLECULE 1; MALONALDEHYDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; FEMALE; HUMAN; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0029979186     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90226-7     Document Type: Article

References (25)

1. Ruosladti E: Integrins. J Clin Invest 87:1-5, 1991
2. Springer T: Adhesion receptors of the immune system. Nature 346:425-434, 1990
3. Blake DR, Allen R, Lunec J: Free radicals in biological system. A review oriented to inflammatory processes. Br Med Bull 43:371-375, 1987.
4. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
5. Ceriello A, Quatraro A, Giugliano D: Diabetes mellitus and hypertension: The role of hyperglycaemia through oxidative stress. Diabetologia 36:265-266, 1993
6. Giugliano D, Ceriello A, Paolisso G: Diabetes mellitus, hypertension, and cardiovascular disease: Which role for oxidative stress? Metabolism 44:363-368, 1995
7. Rothlein R, Mainolfi EA, Czajkowski M, et al: A form of circulating ICAM-1 in human serum. J Immunol 147:3788-3793, 1991
8. Lampeter ER, Kishimoto TK, Rothlein R, et al: Elevated levels of circulating adhesion molecules in IDDM patients and in subjects at risk for IDDM. Diabetes 41:1668-1671, 1992
9. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1037-1057, 1979
10. Mallia AK, Hermanson GT, Krohn RS, et al: Preparation and use of a boronic acid affinity chromatography for separation and quantification of glycosylated hemoglobin. Ann Lett 14:649-661, 1981
11. Bachorik PS, Kwiterovich PO: Measurement of plasma cholesterol, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol, in Hommes FA (ed): Techniques in Diagnostic Human Biochemical Genetics. A Laboratory Manual. New York, NY, Wiley-Liss, 1991, pp 425-459
12. Friedewald WT, Lewy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
13. Conti M, Morand PC, Levillain P, et al: Improved fluorometric determination of malonaldehyde. Clin Chem 37:1273-1275, 1991
14. Lopes-Virella MF, Virella G: Immune mechanism of atherosclerosis in diabetes mellitus. Diabetes 41:86-91, 1992 (suppl 2)
15. Wilson PWF, Cupples LA, Kannel WB: Is hyperglycemia associated with cardiovascular disease? The Framingham Study. Am Heart J 121:586-590, 1990
16. Kuusisto J, Mykkänen L, Pyörälä K, et al: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43:960-967, 1994
17. Yarnell JWG, Pickering JE, Elwood PC, et al: Does non-diabetic hyperglycemia predict future IHD? - Evidence from the Caerphilly and Speedwell studies. J Clin Epidemiol 47:383-388, 1994
18. 1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 41:202-208, 1992
19. Chisolm GM: The oxidation of lipoproteins: Implications for atherosclerosis, in Spatz L, Bloom AD (eds): Mechanisms and Consequences of Oxidative Damage, New York, NY, Oxford University Press, 1992, pp 78-106
20. Altomare E, Vendemiale G, Chicco D, et al: Increased lipid peroxidation in type II poorly controlled diabetic patients. Diabete Metab 18:264-271, 1992
21. Lorenzi M, Cagliero E: Pathobiology of endothelial and other vascular cells in diabetes mellitus. Call for data. Diabetes 40:653-659, 1991
22. Curcio F, Ceriello A: Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: New insights on the pathophysiological mechanism of diabetic vascular complications. In Vitro Cell Dev Biol 28A:787-790, 1992
23. Tesfamariam B: Free radicals in diabetic endothelial cell dysfunction. Free Rad Biol Med 16:383-391, 1994
24. Ceriello A, Curcio F, Dello Russo P, et al: The defence against free radicals protects endothelial cells from hyperglycaemia-induced plasminogen activator inhibitor 1 over-production. Blood Coag Fibrinol 6:133-137, 1995
25. Curcio F, Pegoraro I, Dello Russo P, et al: SOD and GSH inhibit the high glucose-induced oxidative damage and the PDGF increased secretion in cultured human endothelial cells. Thromb Haemost 74:969-973, 1995